Ceftizoxime Sodium

drug-information.ru

|Ceftizoxime Sodium

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Ceftizoxime Sodium

Pronouncation: (SEFF-tih-ZOX-eem SO-dee-uhm)
Class: Antibiotic, Cephalosporin

Trade Names:
Cefizox
- Powder for Injection 500 mg (2.6 mEq sodium/g)
- Powder for Injection 1 g (2.6 mEq sodium/g)
- Powder for Injection 2 g (2.6 mEq sodium/g)
- Powder for Injection 10 g (2.6 mEq sodium/g)
- Injection 1 g as sodium
- Injection 2 g as sodium

Mechanism of Action

Pharmacology

Inhibits mucopeptide synthesis in bacterial cell wall.

Pharmacokinetics

Distribution

Ceftizoxime is 30% protein bound. It achieves therapeutic levels in various body fluids (eg, CSF in those with inflamed meninges) and body tissues. It is excreted in human milk in low concentrations.

Metabolism

Ceftizoxime is not metabolized.

Elimination

The t ½ is about 1.7 hr. Ceftizoxime is excreted unchanged by the kidneys in 24 hr.

Special Populations

Renal Function Impairment

The t ½ is prolonged. Dosage adjustment is recommended.

Indications and Usage

Treatment of infections of lower respiratory tract, urinary tract, skin and skin structures, bone and joint; treatment of intra-abdominal infections, pelvic inflammatory disease, gonorrhea, septicemia, and meningitis caused by susceptible microorganisms.

Contraindications

Hypersensitivity to cephalosporins.

Dosage and Administration

Adults

IV/IM 1 to 2 g q 8 to 12 hr (life-threatening infections: IV up to 2 g q 4 hr or 3 to 4 g q 8 hr).

Children over 6 mo

IV/IM 50 mg/kg q 6 to 8 hr up to 200 mg/kg/day (max, 12 g/day).

General Advice

  • When giving by IM route, inject deeply into large muscle (eg, upper outer quadrant of gluteus muscle or lateral thigh); massage well. For amounts greater than 2 g, divide dose and administer in different muscle masses.
  • Reconstituted solution should be light yellow to amber. Do not administer if solution is cloudy or precipitate is present.
  • When giving by IV route, administer slowly over 3 to 5 min using direct (bolus) injection. Change IV sites q 48 to 72 hr.
  • When drug is administered by intermittent IV infusion, reconstituted solution can be further diluted with 50 to 100 mL of 0.9% Sodium Chloride or D5W and infused over 30 min.

Storage/Stability

  • Completely thaw frozen preparations at room temperature before use. Do not introduce additives. After thawing, solution is stable for 24 hr at room temperature or for 10 days if refrigerated. Do not refreeze.
  • Store sterile powder at room temperature and protect from light.
  • Reconstituted solution is stable for 96 hr if refrigerated and 24 hr when stored at room temperature.

Drug Interactions

Aminoglycosides

Increased risk of nephrotoxicity.

Probenecid

Inhibition of renal excretion of ceftizoxime.

Incompatibility

Aminoglycosides

Do not add aminoglycosides to ceftizoxime solutions because inactivation of both drugs may result; administer at separate sites if concurrent therapy is indicated.

Laboratory Test Interactions

May cause false-positive urine glucose test results with Benedict solution, Fehling solution, or Clinitest tablets but not with enzyme-based tests (eg, Clinistix , Tes-tape ); false-positive test results for proteinuria with acid and denaturization-precipitation tests; false-positive direct Coombs test results in certain patients (eg, those with azotemia); false elevations in urinary 17-ketosteroid values.

Adverse Reactions

GI

Nausea; vomiting; diarrhea; anorexia; abdominal pain or cramps; flatulence; colitis, including pseudomembranous colitis.

Genitourinary

Pyuria; renal dysfunction; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy.

Hematologic

Eosinophilia; neutropenia; lymphocytosis; leukocytosis; thrombocytopenia; decreased platelet function; anemia; aplastic anemia; hemorrhage.

Hepatic

Hepatic dysfunction; abnormal LFT results.

Miscellaneous

Hypersensitivity, including Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis; candidal overgrowth; serum sickness–like reactions (eg, skin rashes, polyarthritis, arthralgia, fever); phlebitis; thrombophlebitis and pain at injection site.

Precautions

Monitor

Response to therapy

Monitor patient"s response to therapy. Notify health care provider if infection does not appear to improve or worsens.

Side effects

Monitor patient for GI, DERM, and general body side effects, and signs of superinfection. Inform health care provider if noted and significant. Immediately report severe diarrhea, diarrhea containing blood or pus, or severe abdominal cramping.


Pregnancy

Category B .

Lactation

Excreted in breast milk.

Children

Safety and efficacy in infants under 6 mo not established. In infants, consider benefits relative to risks.

Hypersensitivity

Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients because of possible cross-reactivity.

Renal Function

Use drug with caution in patients with baseline renal impairment. Dosage adjustment based on renal function may be required.

Superinfection

May result in bacterial or fungal overgrowth of nonsusceptible micro-organisms.

Pseudomembranous colitis

Consider in patients who develop diarrhea.

Overdosage

Symptoms

Seizures.

Patient Information

  • Remind patient to check body temperature daily. If fever persists for more than a few days or if high fever (> 102°F) or shaking chills are noted, notify health care provider immediately.
  • Advise patient to maintain normal fluid intake while using this medication.
  • Instruct diabetic patient to use enzyme-based tests (eg, Clinistix , Testape ) for monitoring urine glucose because drug may give false results with other tests.
  • Advise patient to report these symptoms to health care provider: nausea, vomiting, diarrhea, sore throat, bruising, bleeding, hives, bone or joint pain.
  • Instruct patient to report signs of superinfection: black “furry” tongue, white patches in mouth, foul-smelling stools, vaginal itching or discharge.
  • Warn patient that diarrhea that contains blood or pus may be a sign of serious disorders. Tell patient to seek medical care and not to treat at home.
  • Instruct patient to seek emergency care immediately if wheezing or difficulty in breathing occurs.
  • Advise patient to avoid ingesting alcohol.




Where can I get more information about Ceftizoxime Sodium ? We recommend to use www.Drugs.com

Typical mistypes for Ceftizoxime Sodium
xeftizoxime sodium, veftizoxime sodium, feftizoxime sodium, deftizoxime sodium, cwftizoxime sodium, csftizoxime sodium, cdftizoxime sodium, crftizoxime sodium, c4ftizoxime sodium, c3ftizoxime sodium, cedtizoxime sodium, cectizoxime sodium, cevtizoxime sodium, cegtizoxime sodium, cettizoxime sodium, certizoxime sodium, cefrizoxime sodium, ceffizoxime sodium, cefgizoxime sodium, cefyizoxime sodium, cef6izoxime sodium, cef5izoxime sodium, ceftuzoxime sodium, ceftjzoxime sodium, ceftkzoxime sodium, ceftozoxime sodium, ceft9zoxime sodium, ceft8zoxime sodium, ceftixoxime sodium, ceftisoxime sodium, ceftiaoxime sodium, ceftizixime sodium, ceftizkxime sodium, ceftizlxime sodium, ceftizpxime sodium, ceftiz0xime sodium, ceftiz9xime sodium, ceftizozime sodium, ceftizocime sodium, ceftizodime sodium, ceftizosime sodium, ceftizoxume sodium, ceftizoxjme sodium, ceftizoxkme sodium, ceftizoxome sodium, ceftizox9me sodium, ceftizox8me sodium, ceftizoxine sodium, ceftizoxike sodium, ceftizoxije sodium, ceftizoximw sodium, ceftizoxims sodium, ceftizoximd sodium, ceftizoximr sodium, ceftizoxim4 sodium, ceftizoxim3 sodium, ceftizoxime aodium, ceftizoxime zodium, ceftizoxime xodium, ceftizoxime dodium, ceftizoxime eodium, ceftizoxime wodium, ceftizoxime sidium, ceftizoxime skdium, ceftizoxime sldium, ceftizoxime spdium, ceftizoxime s0dium, ceftizoxime s9dium, ceftizoxime sosium, ceftizoxime soxium, ceftizoxime socium, ceftizoxime sofium, ceftizoxime sorium, ceftizoxime soeium, ceftizoxime soduum, ceftizoxime sodjum, ceftizoxime sodkum, ceftizoxime sodoum, ceftizoxime sod9um, ceftizoxime sod8um, ceftizoxime sodiym, ceftizoxime sodihm, ceftizoxime sodijm, ceftizoxime sodiim, ceftizoxime sodi8m, ceftizoxime sodi7m, ceftizoxime sodiun, ceftizoxime sodiuk, ceftizoxime sodiuj, eftizoxime sodium, cftizoxime sodium, cetizoxime sodium, cefizoxime sodium, ceftzoxime sodium, ceftioxime sodium, ceftizxime sodium, ceftizoime sodium, ceftizoxme sodium, ceftizoxie sodium, ceftizoxim sodium, ceftizoximesodium, ceftizoxime odium, ceftizoxime sdium, ceftizoxime soium, ceftizoxime sodum, ceftizoxime sodim, ceftizoxime sodiu, ecftizoxime sodium, cfetizoxime sodium, cetfizoxime sodium, cefitzoxime sodium, ceftzioxime sodium, ceftiozxime sodium, ceftizxoime sodium, ceftizoixme sodium, ceftizoxmie sodium, ceftizoxiem sodium, ceftizoxim esodium, ceftizoximes odium, ceftizoxime osdium, ceftizoxime sdoium, ceftizoxime soidum, ceftizoxime soduim, ceftizoxime sodimu, cceftizoxime sodium, ceeftizoxime sodium, cefftizoxime sodium, cefttizoxime sodium, ceftiizoxime sodium, ceftizzoxime sodium, ceftizooxime sodium, ceftizoxxime sodium, ceftizoxiime sodium, ceftizoximme sodium, ceftizoximee sodium, ceftizoxime sodium, ceftizoxime ssodium, ceftizoxime soodium, ceftizoxime soddium, ceftizoxime sodiium, ceftizoxime sodiuum, ceftizoxime sodiumm, etc.



© Copyright by drug-information.ru 2001-2019. All rights reserved